Supply Chain Brain
NOVEMBER 14, 2020
Daniel Hartnett, associate managing director of the Compliance Risk & Diligence Practice of Kroll, advises on the steps that pharmaceutical companies should take to reduce the risk of dealing with third parties, as they develop a COVID-19 vaccine.
NC State SCRC
NOVEMBER 14, 2020
What should organizations do when confronted by a global disruption like the pandemic? This question was faced by many companies and private sector organizations who were faced with a sudden need for PPE and other supplies, and discovered that all supply had been shut down. Supply chains ground to a standstill, and both large and small companies faced dire situations where work stoppages due to a lack of material spread like a domino effect to every region of the world.
Expert insights. Personalized for you.
102 
Let's personalize your content